免疫疗法
抗原
医学
免疫学
CD8型
细胞毒性T细胞
病毒学
疾病
T细胞
免疫
病毒
树突状细胞
癌症研究
生物
免疫系统
病理
体外
生物化学
作者
Cornelis J.M. Melief,Sjoerd H. van der Burg
摘要
This Review deals with recent progress in the immunotherapy of established (pre)malignant disease of viral or non-viral origin by synthetic vaccines capable of inducing robust T-cell responses. The most attractive vaccine compounds are synthetic long peptides (SLP) corresponding to the sequence of tumour viral antigens or tumour-associated non-viral antigens. Crucial to induction of therapeutic T-cell immunity is the capacity of SLP to deliver specific cargo to professional antigen-presenting cells (dendritic cells (DC)). Proper DC activation then induces the therapeutic CD4+ and CD8+ T-cell responses that are associated with regression of established (pre)malignant lesions, including those induced by high-risk human papilloma virus.
科研通智能强力驱动
Strongly Powered by AbleSci AI